Evaluation of the affordability of tumor-targeted drugs in Beijing based on the national centralized procurement of drugs
Objective To investigate the changes of affordability of tumor-targeted drugs in Beijing before and after the implementation of national centralized procurement of drugs(hereinafter referred to as"centralized procurement").Methods Based on the price of tumor-targeted drugs in the first nine batches of centralized procurement and we used the improved WHO/HAI standard survey method and the impact of centralized procurement policies on tumor-targeted drugs was evaluated using the minimum daily wage standard and annual per capita disposable income as indicators.Results The prices of 12 kinds of drugs all decreased by 25.05%to 97.71%and the monthly drug expenditure decreased from 10.33 to 1030.96 times of the minimum daily wage before policy to 2.70 to 189.36 times after policy.The working years required for urban uninsured,urban workers′ medical insurance,and urban and rural residents′ medical insurance patients to pay the annual treatment cost decreased from 0.12 to 11.28 years,0.03 to 6.08 years,0.04 to 8.90 years before the policy to 0.03 to 2.23 years,0.02 to 0.35 years,and 0.02 to 0.51 years after the policy,respectively,and the working years for rural uninsured and urban and rural residents′ medical insurance patients decreased from 0.31 to 27.62 years and 0.10 to 21.79 years before the policy to 0.07 to 5.61 years and 0.04 to 1.27 years after the policy,respectively.Conclusion After the implementation of centralized procurement,the affordability of antitumor targeted drugs for residents in Beijing has improved significantly.However,there are still some drugs with high basic prices that have a certain economic pressure on patients.
national centralized procurement of drugstumor-targeted drugsaffordability
万方数据
维普
